← For professionals Versión en español
MedCost Clearmedcostclear.com · data checked Nov 15, 2026

GLP-1 coverage denied: appeal routes and deadlines by coverage type

From federal rules, CMS and HealthCare.gov pages and model notices. General information, not legal or medical advice.

Read the notice for three things

Deadlines by coverage type[1][2][3][4][5][6][7][8]

CoverageFirst appeal: deadlineDecision timeNext level
Medicare Part D / Medicare Advantage with drugsRedetermination: 65 days from the date on the notice7 days; fast 72 hoursIndependent Review Entity, 65 days
Marketplace / individual planInternal appeal (one level): 180 days30 days (60 if already paid); urgent 72 hoursExternal review within 4 months; decided in 45 days (72 hours urgent)
Job-based planInternal appeal: at least 180 days30 days (60 if already paid); urgent 72 hoursExternal review within 4 months
Medicaid managed carePlan appeal: 60 days from the date on the notice30 days; fast 72 hoursState fair hearing, 90 to 120 days (state sets)
Medicaid fee-for-serviceState fair hearing: state sets, at most 90 days from mailingState rules—
Medicare GLP-1 BridgePrescriber resubmits the prior authorization for re-review——

If the notice gives a shorter deadline, follow the notice.

Medicare Part D: exceptions

Exclusions: be honest with your client

Free help

Official sources (date our archive last confirmed each one)

  1. CMS-10146 Notice of Denial of Medicare Part D Drug Coverage. https://www.cms.gov/files/zip/notice-denial-part-d-prescription-drug-cvg-english-form-instructs-cms-10146-eff-010125.zip — checked Nov 15, 2026
  2. CMS: Reconsideration by the Part D Independent Review Entity. https://www.cms.gov/medicare/appeals-grievances/prescription-drug/reconsiderations — checked Nov 15, 2026
  3. 29 CFR 2560.503-1 (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-29?part=2560&section=2560.503-1 — checked Nov 15, 2026
  4. HealthCare.gov: Internal appeals. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/ — checked Nov 15, 2026
  5. 45 CFR 147.136 (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-45?part=147&section=147.136 — checked Nov 15, 2026
  6. 42 CFR Part 438, Subpart F (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=438&subpart=F — checked Nov 15, 2026
  7. 42 CFR Part 431, Subpart E (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=431&subpart=E — checked Nov 15, 2026
  8. CMS: Medicare GLP-1 Bridge information for prescribers. https://www.cms.gov/files/document/glp-1-prescribers-c-1.pdf — checked Nov 15, 2026
  9. CMS: Exceptions (Part D). https://www.cms.gov/medicare/appeals-grievances/prescription-drug/exceptions — checked Nov 15, 2026
  10. 42 CFR Part 423, Subpart M (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=423&subpart=M — checked Nov 15, 2026
  11. CMS: Coverage Determinations (Part D). https://www.cms.gov/medicare/appeals-grievances/prescription-drug/coverage-determinations — checked Nov 15, 2026
  12. 42 U.S.C. 1396r-8 (GovInfo). https://www.govinfo.gov/content/pkg/USCODE-2023-title42/html/USCODE-2023-title42-chap7-subchapXIX-sec1396r-8.htm — checked Nov 15, 2026
  13. 42 U.S.C. 1395w-102 (GovInfo). https://www.govinfo.gov/content/pkg/USCODE-2023-title42/html/USCODE-2023-title42-chap7-subchapXVIII-partD-subpart1-sec1395w-102.htm — checked Nov 15, 2026
  14. CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
  15. U.S. Department of Labor, Technical Release 2014-01. https://www.dol.gov/agencies/ebsa/employers-and-advisers/guidance/technical-releases/14-01 — checked Nov 15, 2026
  16. HHS/DOL model notice of final internal adverse benefit determination. https://www.cms.gov/files/document/final-internal-adverse-benefit-determination-model-standard.docx — checked Nov 15, 2026
  17. CMS: HHS-Administered Federal External Review Process. https://www.cms.gov/cciio/programs-and-initiatives/consumer-support-and-information/csg-ext-appeals-facts — checked Nov 15, 2026

Current version: https://medcostclear.com/insurance/glp1-denial-appeal/ · Sheet built Nov 15, 2026. How we keep it current: archived daily; flagged after 7 days without a check; copied by hand (the site blocks automated copies); flagged after 90 days.

Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.